Category | Subcategory | No. studies | No. strains | Prevalence (%) (95% CI) |
---|---|---|---|---|
FRSA | ||||
Overall | FRSA/S. aureus | 120 | 7562/157,220 | 0.5 (4.6–5.4) |
Country | Australia | 6 | 796/15,781 | 4.8 (3.4–6.2) |
Belgium | 2 | 25/663 | 3.6 (2.2–5.0) | |
Canada | 5 | 376/6257 | 6.3 (3.2–9.3) | |
China | 4 | 206/2156 | 5.3 (0.6–10.0) | |
France | 7 | 132/3120 | 5.0 (3.2–6.8) | |
Germany | 6 | 94/2424 | 4.7 (2.8–6.6) | |
India | 2 | 6/173 | 3.5 (0.7–6.2) | |
Iran | 3 | 13/353 | 3.4 (1.5–5.3) | |
Israel | 2 | 8/220 | 3.6 (1.1–6.0) | |
Kuwait | 3 | 93/1370 | 6.8 (5.4–8.1) | |
Malaysia | 5 | 102/1956 | 5.3 (3.6–6.9) | |
Malta | 2 | 374/25 | 6.5 (4.0–9.1) | |
Netherland | 2 | 63/1193 | 5.2 (4.0–6.5) | |
Norway | 2 | 12/136 | 8.3 (3.7–12.9) | |
Poland | 2 | 10/291 | 3.4 (1.3–5.5) | |
Spain | 2 | 5/113 | 4.2 (0.5–8.0) | |
Sweden | 2 | 38/616 | 5.4 (3.6–7.2) | |
Switzerland | 2 | 18/317 | 5.6 (3.1–8.2) | |
Taiwan | 4 | 75/1134 | 5.9 (1.9–9.9) | |
Turkey | 9 | 223/3319 | 5.8 (3.7–7.9) | |
UK | 22 | 4715/105,038 | 4.8 (4.1–5.5) | |
USA | 3 | 26/653 | 3.7 (2.3–5.2) | |
FRMRSA | ||||
Overall | FRMRSA/S. aureus | 79 | 2193/94,238 | 2.6 (2.3–2.9) |
Country | Australia | 2 | 33/2881 | 1.1 (0.8–1.5) |
Canada | 4 | 276/4145 | 4.5 (0.2–8.9) | |
China | 4 | 5/295 | 1.3 (0.0–2.5) | |
France | 3 | 33/2141 | 1.4 (0.3–2.5) | |
Germany | 2 | 11/656 | 2.0 (0.0–4.5) | |
Greece | 2 | 5/142 | 2.1 (0.3–3.9) | |
Iran | 4 | 14/844 | 1.2 (0.4–1.9) | |
Korea | 2 | 19/653 | 2.1 (0.0–5.0) | |
Kuwait | 2 | 91/1427 | 4.5 (0.1–9.1) | |
Malaysia | 4 | 84/1877 | 4.5 (1.9–7.2) | |
Pakistan | 2 | 47/691 | 4.9 (0.2–12.7) | |
Poland | 2 | 8/338 | 2.0 (0.5–3.5) | |
Taiwan | 2 | 2/124 | 0.9 (0.0–2.1) | |
Turkey | 7 | 77/1324 | 5.3 (2.7–7.9) | |
UK | 10 | 1167/67,758 | 1.4 (1.0–1.9) | |
USA | 3 | 26/653 | 3.7 (2.3–5.2) | |
FRMSSA | ||||
Overall | FRMRSA/MRSA | 72 | 3211/50,078 | 5.8 (5.0–6.6) |
Country | Australia | 3 | 117/1470 | 7.7 (1.1–14.3) |
Canada | 4 | 269/3477 | 6.4 (4.1–8.8) | |
China | 3 | 4/126 | 2.9 (0.0–5.8) | |
France | 2 | 74/1437 | 7.8 (0.0–19.0) | |
Germany | 2 | 27/253 | 10.3 (6.5–14.0) | |
Iran | 3 | 10/253 | 3.5 (1.2–5.7) | |
Kuwait | 3 | 847/7002 | 9.3 (3.6–15.1) | |
Malaysia | 4 | 84/1642 | 4.8 (3.8–5.9) | |
Pakistan | 2 | 47/583 | 6.6 (4.6–8.6) | |
Serbia | 2 | 6/144 | 3.6 (0.6–6.7) | |
Taiwan | 3 | 99/716 | 8.6 (0.4–16.7) | |
Turkey | 5 | 49/796 | 5.6 (2.7–8.6) | |
UK | 16 | 1374/27,138 | 5.1 (4.1–6.1) | |
USA | 3 | 26/653 | 3.7 (2.3–5.2) | |
FRMSSA | ||||
Overall | FRMSSA/S. aureus | 9 | 939/11,992 | 6.7 (5.4–7.9) |
Country | UK | 4 | 906/11,265 | 8.0 (7.3–8.8) |
Overall | FRMSSA/MSSA | 42 | 2437/70,438 | 3.0 (2.6–3.5) |
Country | Australia | 2 | 60/1734 | 3.4 (2.6–4.3) |
Canada | 2 | 62/2178 | 3.6 (0.6–6.6) | |
China | 3 | 37/2203 | 1.5 (1.0–2.1) | |
Germany | 3 | 22/674 | 2.9 (1.7–4.2) | |
Malaysia | 2 | 10/348 | 2.2 (0.0–5.1) | |
Turkey | 4 | 10/382 | 1.8 (0.5–3.1) | |
UK | 13 | 2184/61,050 | 3.5 (2.8–4.2) |